Ikenaka K, Fukushima M, Nakamura H, Okamoto M, Shirasaka T, Fujii S
Gan. 1981 Aug;72(4):590-7.
The metabolism of pyrimidine nucleotides in various tissues and tumor cells of rodents was investigated. Ribonucleoside diphosphate reductase, thymidine monophosphate kinase and DNA polymerase (alpha, beta) were specifically localized in tumor cells, i.e., the activities of these enzymes in tumor cells were at least three times higher than those in normal tissues, including rapidly growing tissues, such as bone marrow, thymus, and spleen. The activities of deoxycytidine monophosphate deaminase and all the nucleoside kinase were high not only in tumor cells, but also in rapidly growing normal tissues, so that these enzymes are unsuitable as targets for cancer chemotherapy. The tissue distribution of other enzymes, including orotate phosphoribosyltransferases, cytidine triphosphate synthetase, thymidine monophosphate synthase, nucleoside phosphorylases and cytidine deaminase had no relation with the cell growth rate. AH130 tumor cells and the thymus showed specific increases in the activities of enzymes involved in de novo DNA synthesis. In contrast, Yoshida sarcoma and bone marrow showed high activities of enzymes in the salvage pathway of DNA synthesis, which suggested that the two tumors have different patterns of nucleotide metabolism.
对啮齿动物各种组织和肿瘤细胞中的嘧啶核苷酸代谢进行了研究。核糖核苷二磷酸还原酶、胸苷一磷酸激酶和DNA聚合酶(α、β)特异性定位于肿瘤细胞中,即这些酶在肿瘤细胞中的活性比正常组织(包括快速生长的组织,如骨髓、胸腺和脾脏)中的活性至少高3倍。脱氧胞苷一磷酸脱氨酶和所有核苷激酶的活性不仅在肿瘤细胞中高,在快速生长的正常组织中也高,因此这些酶不适合作为癌症化疗的靶点。其他酶的组织分布,包括乳清酸磷酸核糖基转移酶、胞苷三磷酸合成酶、胸苷一磷酸合成酶、核苷磷酸化酶和胞苷脱氨酶,与细胞生长速率无关。AH130肿瘤细胞和胸腺中参与从头合成DNA的酶的活性有特异性增加。相比之下,吉田肉瘤和骨髓中DNA合成补救途径中的酶活性较高,这表明这两种肿瘤具有不同的核苷酸代谢模式。